mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.03 |
0.3 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.046 |
0.3 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.3 |
mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |